Literature DB >> 19427341

NF-kappaB and phosphatidylinositol 3-kinase activity mediates the HCMV-induced atypical M1/M2 polarization of monocytes.

Gary Chan1, Elizabeth R Bivins-Smith, M Shane Smith, Andrew D Yurochko.   

Abstract

Human cytomegalovirus infection of monocytes stimulates a unique monocyte differentiation reprogramming resulting in polarization towards an M1 pro-inflammatory macrophage that simultaneously exhibits characteristics of an M2 anti-inflammatory macrophage. Our laboratory has previously shown that HCMV infection stimulates monocyte NF-kappaB and PI(3)K activities and now provides evidence that these cellular factors are essential for the HCMV-induced polarization of infected monocytes/macrophages. We find that the induction of NF-kappaB and PI(3)K activities following HCMV infection was required for the initiation of monocyte-to-macrophage differentiation. HCMV-infected monocytes treated with Bay11-7802 (an inhibitor of NF-kappaB activity) or LY294002 [an inhibitor of PI(3)K activity] prior to infection exhibited a small, round and monocyte-like undifferentiated morphology and the lack of CD68 upregulation (a macrophage differentiation marker). Detailed transcriptome analysis revealed 48%, 7% and 31% of HCMV-induced M1-associated genes were dependent on NF-kappaB, PI(3)K or both activities, respectively; while 100% of HCMV-induced M2-associated genes required both NF-kappaB and PI(3)K activities. Functionally, we demonstrated that NF-kappaB and PI(3)K activities were critical for the production of M1- and M2-associated cytokines/chemokines, in HCMV-induced differentiating monocytes. Supernatant from HCMV-infected monocytes pretreated with Bay11-7802 or LY294002 exhibited an 80% and 67% reduction in cell motility-inducing activity. Overall, these data show that HCMV usurps monocyte NF-kappaB and PI(3)K signal transduction pathways to induce the unique polarization of HCMV-infected monocytes needed for the earliest steps in the viral dissemination and persistence strategy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19427341      PMCID: PMC2736317          DOI: 10.1016/j.virusres.2009.04.026

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  19 in total

1.  Previous cytomegalovirus infection and restenosis after aggressive angioplasty with provisional stenting.

Authors:  Christian Mueller; John McB Hodgson; Hans-Peter Bestehorn; Martin Brutsche; Andrè P Perruchoud; Stephan Marsch; Helmut Roskamm; Heinz J Buettner
Journal:  J Interv Cardiol       Date:  2003-08       Impact factor: 2.279

2.  Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.

Authors:  Fernando O Martinez; Siamon Gordon; Massimo Locati; Alberto Mantovani
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

Review 3.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

4.  Virus infections after transplantation in man. Brief review.

Authors:  M Ho
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

5.  Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression.

Authors:  A D Yurochko; E S Huang
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

6.  Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage.

Authors:  Gary Chan; Elizabeth R Bivins-Smith; M Shane Smith; Patrick M Smith; Andrew D Yurochko
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence.

Authors:  M Shane Smith; Gretchen L Bentz; J Steven Alexander; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

8.  HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner.

Authors:  M Shane Smith; Gretchen L Bentz; Patrick M Smith; Elizabeth R Bivins; Andrew D Yurochko
Journal:  J Leukoc Biol       Date:  2004-04-23       Impact factor: 4.962

9.  Transcriptome analysis of NF-kappaB- and phosphatidylinositol 3-kinase-regulated genes in human cytomegalovirus-infected monocytes.

Authors:  Gary Chan; Elizabeth R Bivins-Smith; M Shane Smith; Andrew D Yurochko
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

10.  Roles of phosphatidylinositol 3-kinase and NF-kappaB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence.

Authors:  M Shane Smith; Elizabeth R Bivins-Smith; A Michael Tilley; Gretchen L Bentz; Gary Chan; Jessica Minard; Andrew D Yurochko
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

View more
  51 in total

Review 1.  Is HCMV a tumor promoter?

Authors:  Liliana Soroceanu; Charles S Cobbs
Journal:  Virus Res       Date:  2010-10-29       Impact factor: 3.303

2.  Consensus on the role of human cytomegalovirus in glioblastoma.

Authors:  Kristine Dziurzynski; Susan M Chang; Amy B Heimberger; Robert F Kalejta; Stuart R McGregor Dallas; Martine Smit; Liliana Soroceanu; Charles S Cobbs
Journal:  Neuro Oncol       Date:  2012-02-08       Impact factor: 12.300

3.  Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.

Authors:  Meaghan H Hancock; Jay A Nelson
Journal:  Virology (Hyderabad)       Date:  2017-07-31

4.  Human Cytomegalovirus Glycoprotein-Initiated Signaling Mediates the Aberrant Activation of Akt.

Authors:  Jamil Mahmud; Michael J Miller; Aaron M Altman; Gary C Chan
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

5.  Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs).

Authors:  Antonio Sica; Chiara Porta; Sara Morlacchi; Stefania Banfi; Laura Strauss; Monica Rimoldi; Maria Grazia Totaro; Elena Riboldi
Journal:  Cancer Microenviron       Date:  2011-09-24

6.  Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation.

Authors:  Carina Bayer; Stefania Varani; Li Wang; Paul Walther; Shaoxia Zhou; Sarah Straschewski; Max Bachem; Cecilia Söderberg-Naucler; Thomas Mertens; Giada Frascaroli
Journal:  J Virol       Date:  2012-10-10       Impact factor: 5.103

7.  Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells.

Authors:  Jung Heon Kim; Donna Collins-McMillen; Jason C Buehler; Felicia D Goodrum; Andrew D Yurochko
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

8.  STING Sensing of Murine Cytomegalovirus Alters the Tumor Microenvironment to Promote Antitumor Immunity.

Authors:  Nicole A Wilski; Colby Stotesbury; Christina Del Casale; Brian Montoya; Eric Wong; Luis J Sigal; Christopher M Snyder
Journal:  J Immunol       Date:  2020-04-13       Impact factor: 5.422

9.  Murine Cytomegalovirus Infection of Melanoma Lesions Delays Tumor Growth by Recruiting and Repolarizing Monocytic Phagocytes in the Tumor.

Authors:  Nicole A Wilski; Christina Del Casale; Timothy J Purwin; Andrew E Aplin; Christopher M Snyder
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

10.  Human Cytomegalovirus Stimulates the Synthesis of Select Akt-Dependent Antiapoptotic Proteins during Viral Entry To Promote Survival of Infected Monocytes.

Authors:  Megan A Peppenelli; Kyle C Arend; Olesea Cojohari; Nathaniel J Moorman; Gary C Chan
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.